Sionna Therapeutics (SION) Approves 46% Job Cut. Can a New Trial Make its Cash More Productive?
Sionna Therapeutics, Inc.
Sionna Therapeutics Inc. (SION)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 9,905,045 | $435,722,930 | 3.79% | |
| 2. | Viking Global Andreas Halvorsen | 3,195,181 | $140,556,012 | 0.4% | |
| 3. | OrbiMed Advisors Samuel Isaly | 2,555,877 | $112,433,029 | -28% | 2.08% |
| 4. | Enavate Sciences James Boylan | 2,478,030 | $109,008,540 | 31.56% | |
| 5. | Adage Capital Management Phill Gross And Robert Atchinson | 1,600,000 | $70,384,000 | +967% | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.84 | 60,000 | $950,400.00 | 6,744,962 | 2025-06-27 | Filing | |
| $18.00 | 1,125,000 | $20,250,000.00 | 6,684,962 | 2025-02-10 | Filing | |
| $18.00 | 102,414 | $1,843,452.00 | 2,324,498 | 2025-02-10 | Filing | |
| $18.00 | 1,022,586 | $18,406,548.00 | 6,923,365 | 2025-02-10 | Filing | |
| $18.00 | 550,000 | $9,900,000.00 | 3,704,959 | 2025-02-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.46 | 33,800 | $252,148.00 | 3,448,812 | 2026-09-17 | Filing | |
| $6.32 | 3,415,011 | $21,582,869.52 | 3,482,612 | 2026-09-17 | Filing | |
| $44.86 | 85,918 | $3,854,281.48 | 2,469,959 | 2026-07-07 | Filing | |
| $44.86 | 85,918 | $3,854,281.48 | 2,469,959 | 2026-07-07 | Filing | |
| $43.60 | 10,250 | $446,862.08 | 0 | 2026-07-06 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 925 | $4,866 | 0% | |
| 2. | 716 | $3,766 | 0% |
News See All
One Company's Clinical Miss Is Another's Moat: Vertex Rallies as Sionna's CF Bet Collapses
Cystic fibrosis investors came to learn a harsh lesson on August 10 about how concentrated a market can be: Sionna Therapeutics, Inc.
Vertex Stock (VRTX) Soars 7% as Rival Sionna (SION) Crashes 92% on Failed Drug Trial
Shares of American biotech company Vertex Pharmaceuticals ($VRTX) jumped about 7% on Monday after its top rival Sionna Therapeutics ($SION) reporte...
Wedbush Initiates Coverage of Sionna Therapeutics (SION)
Sionna Therapeutics, Inc. (NASDAQ:SION) is one of the best small cap stocks to buy for 10x potential. Wedbush initiated coverage of Sionna Therapeutics, Inc.
15 Best Small Cap Stocks to Buy for 10x Potential
In this article, we will look at the 15 Best Small Cap Stocks to Buy for 10x Potential.
10 Stocks Insiders Are Buying This Year
In this article, we will take a detailed look at 10 Stocks Insiders Are Buying This Year. We previously covered Why These 15 Software Stocks Are Skyrocketing So Far in 2025.